FWIA
HAE icon

Fort Washington Investment Advisors’s Haemonetics HAE Stock Holding History

Fort Washington Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62.3M Sell
830,925
-10,092
-1% -$648K 0.31% 83
2026
Q1 		$47.4M Buy
841,017
+124,020
+17% +$8.08M 0.26% 99
2025
Q4 		$57.5M Buy
716,997
+10,685
+2% +$718K 0.31% 79
2025
Q3 		$34.4M Buy
706,312
+187,630
+36% +$11.6M 0.19% 121
2025
Q2 		$38.7M Buy
518,682
+1,596
+0.3% +$106K 0.22% 108
2025
Q1 		$32.9M Buy
517,086
+242,956
+89% +$16.5M 0.2% 112
2024
Q4 		$21.4M Sell
274,130
-35,220
-11% -$2.83M 0.13% 153
2024
Q3 		$24.9M Buy
309,350
+79,687
+35% +$6.44M 0.15% 130
2024
Q2 		$19M Buy
229,663
+50,902
+28% +$4.48M 0.12% 158
2024
Q1 		$15.3M Buy
+178,761
New +$14M 0.1% 171
2021
Q2 		– Sell
-104,110
Closed -$11.6M – 513
2021
Q1 		$11.6M Buy
104,110
+22,408
+27% +$2.77M 0.11% 156
2020
Q4 		$9.7M Sell
81,702
-11,480
-12% -$1.24M 0.1% 178
2020
Q3 		$8.13M Sell
93,182
-86,106
-48% -$7.53M 0.09% 167
2020
Q2 		$16.1M Buy
179,288
+101,000
+129% +$10.2M 0.18% 98
2020
Q1 		$7.8M Sell
78,288
-27,800
-26% -$3.01M 0.11% 153
2019
Q4 		$12.2M Buy
106,088
+7,800
+8% +$944K 0.13% 170
2019
Q3 		$12.4M Sell
98,288
-23,600
-19% -$3M 0.14% 145
2019
Q2 		$14.7M Sell
121,888
-43,000
-26% -$4.23M 0.16% 120
2019
Q1 		$14.4M Sell
164,888
-5,000
-3% -$455K 0.16% 133
2018
Q4 		$17M Hold
169,888
– – 0.21% 105
2018
Q3 		$19.5M Sell
169,888
-9,150
-5% -$947K 0.19% 128
2018
Q2 		$16.1M Sell
179,038
-56,000
-24% -$4.73M 0.16% 166
2018
Q1 		$17.2M Sell
235,038
-49,100
-17% -$3.37M 0.18% 119
2017
Q4 		$16.5M Buy
+284,138
New +$15M 0.16% 137

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fort Washington Investment Advisors's HAE Position: Q2 2026 in Review

Fort Washington Investment Advisors reduced its Haemonetics (HAE) stake by 1.2% in Q2 2026, selling an estimated $648K and leaving 830,925 shares worth $62.3M. The position accounts for 0.31% of the portfolio, ranked #83.

Fort Washington Investment Advisors first reported a position in HAE in Q4 2017 and has held it in 24 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Fort Washington Investment Advisors held 830,925 shares of Haemonetics worth $62.3M as of Q2 2026.
  • Fort Washington Investment Advisors sold 10,092 Haemonetics shares in Q2 2026, an estimated $648K.
  • Haemonetics made up 0.31% of Fort Washington Investment Advisors's portfolio in Q2 2026, its #83 holding.
  • Fort Washington Investment Advisors first reported a position in Haemonetics in Q4 2017 and has held it in 24 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Fort Washington Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.